Keryx Biopharmaceuticals to Host Conference Call on Second Quarter 2013 Financial Results

Published: Jul 31, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, July 30, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Thursday, August 1, 2013 at 8:30 a.m. EDT to discuss results for the second quarter ended June 30, 2013 and a business outlook for the remainder of 2013. Ron Bentsur, Chief Executive Officer of Keryx, will host the call.

Help employers find you! Check out all the jobs and post your resume.

Back to news